Exercise as medicine: new trial tests workouts for heart condition
NCT ID NCT05818605
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether 24 weeks of moderate exercise (three 60-minute sessions per week) can improve symptoms and heart function in people with hypertrophic cardiomyopathy, a condition where the heart muscle is thickened. About 70 participants will be randomly assigned to either the exercise program or their usual activity. Researchers will measure changes in exercise capacity, heart strain, and other markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Moderate Intensity Exercise Program
- What this could lead to
- If it works, this could show that structured exercise safely improves exercise capacity and quality of life for people with hypertrophic cardiomyopathy.
- What could go wrong
- This is a small, early-stage trial with only 70 participants. Exercise may not improve heart function, and some patients might experience discomfort or risks from increased activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California - San Francisco
RECRUITINGSan Francisco, California, 94143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans may unlock hidden risks in minority communities
- Global registry aims to unlock clues for heart transplant success in adults born with heart defects
- Heart conditions in kids: study reveals impact on daily life and play
- Could a simple scan unlock better heart treatment?
- Gene hunt launched for kids with heart muscle disease
- Canadian study tracks Real-World use of heart drug mavacamten